0001225208-20-000298.txt : 20200103 0001225208-20-000298.hdr.sgml : 20200103 20200103162049 ACCESSION NUMBER: 0001225208-20-000298 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200101 FILED AS OF DATE: 20200103 DATE AS OF CHANGE: 20200103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mirviss Jeffrey B. CENTRAL INDEX KEY: 0001566094 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 20505752 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2020-01-01 0000885725 BOSTON SCIENTIFIC CORP BSX 0001566094 Mirviss Jeffrey B. 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 SVP&Pres, Periph Intervent Common Stock 2020-01-01 4 M 0 9939.0000 0.0000 A 103675.0000 D Common Stock 2020-01-01 4 F 0 3191.0000 45.2200 D 100484.0000 D Common Stock 25000.0000 I By GRAT Performance Share Units 2020-01-01 4 M 0 9939.0000 0.0000 D 2019-12-31 2019-12-31 Common Stock 9939.0000 0.0000 D On February 28, 2017, the reporting person was awarded a target number of performance share units under the Company's 2017 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2017 adjusted free cash flow measured against its 2017 financial plan over the one-year performance period ending December 31, 2017 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The Performance Share Units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2019. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. /s/ Scott G. Hodgdon, Attorney-in-Fact 2020-01-03